[Gastric mucosa condition in patients with coronary artery disease and high risk of gastrointestinal bleeding (register REGATTA-1)].
A L KomarovO O ShakhmatovaV V KorobkovaE V KurilinaA G ShuleshovaE P PanchenkoPublished in: Terapevticheskii arkhiv (2021)
Mucosal damage endoscopic signs remains despite long-term proton pump inhibitors therapy in patients with coronary arteries disease and concomitant GIB risk factors, receiving antithrombotic therapy. H. pylori contamination may be the cause of these changes. Therefore, its active screening and eradication is necessary in such patients.
Keyphrases
- risk factors
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- coronary artery
- risk assessment
- oxidative stress
- peritoneal dialysis
- atrial fibrillation
- ultrasound guided
- heart failure
- bone marrow
- mesenchymal stem cells
- human health
- heavy metals
- ulcerative colitis
- transcatheter aortic valve replacement